Wenxin Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Wenxin Zhang has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Fengming Luan
Department of Gastrointestinal Surgery, Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou 310009, China
2 shared publications- Honghai Wu
Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, Institute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China
2 shared publications - Hongjie Guo
Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, Institute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China
2 shared publications - Mingming Zheng
Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, Institute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China
2 shared publications - Qiaojun He
Center for Drug Safety Evaluation and Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China
2 shared publications - Xi Chen
Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, Institute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China
2 shared publications
Latest Publications
- Open Access
- 28 July 2023
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 13 (10) , 4337
Author correction to ‘Mevalonate improves anti-PD-1/PD-L1 efficacy by stabilizing CD274 mRNA’ [Acta Pharmaceutica Sinica B 13 (2023) 2585–2600]
- 28 July 2023
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 13 (10) , 4337
Open AccessAuthor correction to ‘Mevalonate improves anti-PD-1/PD-L1 efficacy by stabilizing CD274 mRNA’ [Acta Pharmaceutica Sinica B 13 (2023) 2585–2600]
- Open Access
- 17 April 2023
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 13 (6) , 2585-2600
Mevalonate improves anti-PD-1/PD-L1 efficacy by stabilizing CD274 mRNA
- 17 April 2023
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 13 (6) , 2585-2600
Open AccessMevalonate improves anti-PD-1/PD-L1 efficacy by stabilizing CD274 mRNA